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Background: The long-term efficiency of CPAP on BP management of hypertensive patients with OSA on top of optimal antihypertensive medication 
has not been investigated.
Methods: We prospectively studied 91 non-sleepy patients (aged 54±9 years, 69 males) with essential hypertension and newly diagnosed 
moderate-to-severe OSA (apnea hypopnea index-AHI>15) for a mean period of 3.1 years. Subjects initially underwent office BP evaluation, and 
were switched to carefully designed antihypertensive treatment targeting office BP<140/90mmHg (<130/80mmHg in diabetics). Subsequently, 
participants underwent regular visits to optimize hypertension management and control. Depending on the acceptance and persistence to CPAP 
application, participants were divided into two groups: As on-CPAP were defined those that adhered to CPAP treatment during the whole follow-up 
period (N=41) while those that did not follow CPAP therapy served as controls (N=50).
Results: At baseline, on-CPAP subjects compared to controls did not differ regarding systolic and diastolic BP levels and number of 
antihypertensive drugs prescribed but exhibited more severe OSA (66% vs. 38%, p=0.015). By the end of the follow-up period, in the entire 
population, office systolic and diastolic BP were significantly lower compared to baseline (133±12 vs. 146±15 and 85±9 vs. 96±10 respectively, 
p<0.001) while number of antihypertensive drugs applied was higher (2.44±1.21 vs. 2.37±1.1, p<0.001). On-CPAP subjects and controls exhibited 
similar BP levels (133±12 vs, 133±13mmHg, 84±9 vs. 85±9mmHg, respectively, p=NS for all), number of patients with controlled hypertension (71% 
vs 70%, p=NS), and number of antihypertensive drugs to achieve BP control (2.28±1.09 vs. 2.11±0.72, p=NS). In multiple linear regression models, 
CPAP application was not associated with changes in BP levels or BP control after controlling for confounders.
Conclusions: In non-sleepy treated hypertensive subjects with OSA, long-term CPAP application is not associated with lower BP levels or a need for 
less antihypertensive drugs for better BP control. Carefully designed drug treatment should be regarded as the mainstay of therapy in these patients.
